Fundraising Fox

Kalogon

Melbourne, US · Founded 2022 · Delaware corporation · 2 known investors

Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.

Founders & leadership

Kalogon was founded in 2022 by Tim Balz, Aaron Jones, and Timothy Balz.

TBTim Balz
Tim BalzFounder & CEO
AJAaron Jones
Aaron JonesCo-Founder & Account Manager
TB
Timothy BalzFounder
CBCarla Borsoi
Carla BorsoiVP of Marketing & Research
JB
Jon BufordEngineering Manager
AKAmanda Krantz
Amanda KrantzVP of Strategy & Business Development
PB
Paul BenzVP of Sales
MK
Marcin KubiakNamed on SEC filing
MB
Mark BergrenNamed on SEC filing
JR
Jeff ReadyNamed on SEC filing

Investors · 2

Reported raises · per SEC filings

Form D private placements

$11.8M disclosed across 4 rounds · 2022–2026

$5.7MraisedJun 2026 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim BalzExecutive Officer, Director
Offering amount
$7M
Amount sold
$5.7M
Minimum investment
$10K
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.9MraisedJun 2026 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim BalzExecutive Officer, Director
Offering amount
$2.9M
Amount sold
$2.9M
Minimum investment
$10K
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.2MraisedJun 2024 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arushi RainaDirector
  • Timothy BalzExecutive Officer, Director
  • Jeff ReadyDirector
  • Marcin KubiakDirector
  • Mark BergrenDirector
Offering amount
$1.2M
Amount sold
$1.2M
Minimum investment
$10K
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.9MraisedAug 2022 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marcin KubiakDirector
  • Tim BalzExecutive Officer, Director
  • Mark BergrenDirector
  • Jeff ReadyDirector
Offering amount
$1.9M
Amount sold
$1.9M
Minimum investment
$150K
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
U.S. Air ForceAir ForcePhase II2022$1.2M
Department of Health and Human ServicesAdministration for Community LivingPhase I2022$99.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Kalogon do?
Kalogon develops advanced seating technologies, including smart cushions, aimed at improving comfort and health for people who must sit for extended periods. The company draws on clinical research and customer feedback to address the health risks and discomfort associated with prolonged sitting.
Who founded Kalogon?
Kalogon was founded by Tim Balz, Aaron Jones, Timothy Balz in 2022.
Who are Kalogon's investors?
Kalogon's investors include Enable Ventures, DeepWork Capital.
How much funding has Kalogon raised?
Kalogon has disclosed $11.8M raised across 4 rounds.
Where is Kalogon headquartered?
Kalogon is headquartered in Melbourne, US.